{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:15:00Z","timestamp":1790666100529,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jns.2023.122779","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T22:52:56Z","timestamp":1699311176000},"page":"122779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ingested (oral) adrenocorticotropic hormone (ACTH) inhibits interleukin-17 in the central nervous system after adoptive transfer of T helper (Th)1\/Th17 T cells in the mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"456","author":[{"given":"Landon J.","family":"Dittel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie N.","family":"Dittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staley A.","family":"Brod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.122779_bb0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1749-6632.1965.tb20218.x","article-title":"Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression, and therapy","volume":"122","author":"Alvord","year":"1965","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2023.122779_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0022-510X(77)90214-3","article-title":"Suppression of acute and chronic experimental allergic encephalomyelitis in strain 13 guinea pigs. A clinical and pathological study","volume":"31","author":"Raine","year":"1977","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2023.122779_bb0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ana.410010207","article-title":"Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis","volume":"1","author":"Wisnewski","year":"1977","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.122779_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-5728(85)90006-2","article-title":"Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat","volume":"10","author":"Feuer","year":"1985","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2023.122779_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ana.410010207","article-title":"Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis","volume":"1","author":"Wisniewski","year":"1977","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.122779_bb0030","first-page":"1693","article-title":"Animal model for multiple sclerosis. Chronic experimental allergic encephalomyelitis in inbred guinea pigs","volume":"77","author":"Raine","year":"1977","journal-title":"N. Y. State J. Med."},{"key":"10.1016\/j.jns.2023.122779_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-5728(94)00188-T","article-title":"Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis","volume":"58","author":"Brod","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2023.122779_bb0040","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4049\/jimmunol.141.4.1143","article-title":"Adoptively transferred experimental autoimmune encephalomylitis in SJL\/J, PL\/J, and (SJLJ X PLJ) F1 mice","volume":"141","author":"McCarron","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ana.410170214","article-title":"Adoptive transfer of murine relapsing experimental autoimmune encephalomyelitis","volume":"17","author":"Lublin","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.122779_bb0050","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4049\/jimmunol.127.4.1420","article-title":"Adoptive transfer of experimental allergic encephalomyelitis in SJL\/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes","volume":"127","author":"Pettinelli","year":"1981","journal-title":"J. Immunol."},{"issue":"Unit 9","key":"10.1016\/j.jns.2023.122779_bb0055","first-page":"7","article-title":"Experimental autoimmune encephalomyelitis (EAE)","volume":"9","author":"Racke","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.jns.2023.122779_bb0060","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1084\/jem.167.4.1350","article-title":"Heterogeneity of helper\/inducer T lymphocytes. II. Effects of interleukin-4 and interleukin-2 producing T cells clones on resting B cells","volume":"167","author":"Boom","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2023.122779_bb0065","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.138.11.3688","article-title":"Two types of murine helper T cells. II. Delayed-type hypersensitivity is mediated by Th1 clones","volume":"138","author":"Cher","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri1807","article-title":"Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells","volume":"6","author":"Dong","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1084\/jem.162.1.188","article-title":"Distinct functional phenotypes of cloned Ia-restricted helper T cells","volume":"162","author":"Kim","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2023.122779_bb0080","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of Neuroinflammatory process in multiple sclerosis","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neulet.2010.04.018","article-title":"Kinetics of IL-17- and interferon-gamma-producing PLPp-specific CD4 T cells in EAE induced by coinjection of PLPp\/IFA with pertussis toxin in SJL mice","volume":"476","author":"Hofstetter","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2023.122779_bb0095","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/eji.201040489","article-title":"EAE mediated by a non-IFN-gamma\/non-IL-17 pathway","volume":"40","author":"Kroenke","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2023.122779_bb0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2567.2009.03204.x","article-title":"Well-controlled proinflammatory cytokine responses of Peyer\u2019s patch cells to probiotic lactobacillus casei","volume":"130","author":"Chiba","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jns.2023.122779_bb0110","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2023.122779_bb0115","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.4049\/jimmunol.178.10.6123","article-title":"Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells","volume":"178","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0120","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1016-8478(23)13236-5","article-title":"Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells","volume":"20","author":"Liu","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jns.2023.122779_bb0130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00436-015-4831-2","article-title":"Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice","volume":"115","author":"Zhao","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.jns.2023.122779_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jneuroim.2010.10.030","article-title":"Ingested (oral) ACTH inhibits EAE","volume":"232","author":"Brod","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2023.122779_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116602","article-title":"Ingested ACTH blocks Th17 production by inhibiting GALT IL-6","volume":"409","author":"Dittel","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2023.122779_bb0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/immunohorizons.2200023","article-title":"Ingested (Oral) adrenocorticotropic hormone inhibits IL-17 in the central nervous system in the mouse model of multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"6","author":"Dittel","year":"2022","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jns.2023.122779_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biopha.2011.11.009","article-title":"Oral ACTH (H.P. Acthar((R))gel) inhibits IL-1 and IL-17 secretion in humans","volume":"66","author":"Brod","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jns.2023.122779_bb0155","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jlb.63.6.740","article-title":"Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia","volume":"63","author":"Delgado","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jns.2023.122779_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/jir.2007.0079","article-title":"Ingested (oral) SIRS peptide 1-21 suppresses type 1 diabetes in NOD mice","volume":"28","author":"Brod","year":"2008","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jns.2023.122779_bb0165","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jns.2023.122779_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1749-6632.1997.tb48392.x","article-title":"The brain is an important target of adrenal steroid actions. A comparison of synthetic and natural steroids","volume":"823","author":"McEwen","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2023.122779_bb0175","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1100\/tsw.2010.173","article-title":"The Melanocortin system in control of inflammation","volume":"10","author":"Catania","year":"2010","journal-title":"TheScientificWorldJOURNAL"},{"key":"10.1016\/j.jns.2023.122779_bb0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tins.2008.04.002","article-title":"Neuroprotective actions of melanocortins: a therapeutic opportunity","volume":"31","author":"Catania","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jns.2023.122779_bb0190","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.162.12.7446","article-title":"POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation","volume":"162","author":"Getting","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2023.122779_bb0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0167-4889(98)00022-6","article-title":"Molecular cloning of the chicken melanocortin 2 (ACTH)-receptor gene","volume":"1403","author":"Takeuchi","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jns.2023.122779_bb0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1189\/jlb.69.1.98","article-title":"Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties","volume":"69","author":"Getting","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jns.2023.122779_bb0205","first-page":"19","article-title":"MC3-R as a novel target for antiinflammatory therapy","volume":"13","author":"Getting","year":"2000","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.jns.2023.122779_bb0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1440-1711.2001.01022.x","article-title":"In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH)","volume":"79","author":"Taylor","year":"2001","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jns.2023.122779_bb0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.immuni.2009.08.010","article-title":"Origin of the lamina propria dendritic cell network","volume":"31","author":"Bogunovic","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jns.2023.122779_bb0220","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0167-5699(96)30065-0","article-title":"Oral cytokine administration","volume":"17","author":"Rollwagen","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jns.2023.122779_bb0225","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00002371-199304000-00006","article-title":"Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta","volume":"13","author":"Witt","year":"1993","journal-title":"J. Immunother."},{"key":"10.1016\/j.jns.2023.122779_bb0230","first-page":"81","article-title":"Is interferon effective after oral administration? The state of the art","volume":"4","author":"Bocci","year":"1990","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.jns.2023.122779_bb0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003088-199121060-00002","article-title":"Absorption of cytokines via the oropharyngeal associated lymphoid tissues - does an unorthodox route improve the therapeutic index of interferon","volume":"21","author":"Bocci","year":"1991","journal-title":"Clin. Pharmacokinet."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23022402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23022402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:03:07Z","timestamp":1758384187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23022402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":47,"alternative-id":["S0022510X23022402"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.122779","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ingested (oral) adrenocorticotropic hormone (ACTH) inhibits interleukin-17 in the central nervous system after adoptive transfer of T helper (Th)1\/Th17 T cells in the mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.122779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122779"}}